These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10431472)

  • 21. What's atypical about atypical antipsychotic drugs?
    Meltzer HY
    Curr Opin Pharmacol; 2004 Feb; 4(1):53-7. PubMed ID: 15018839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manic/hypomanic symptoms induced by atypical antipsychotics: a review of the reported cases.
    Michalopoulou PG; Lykouras L
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):549-64. PubMed ID: 16442194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
    Rajna P
    Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
    Fleischhacker WW; Widschwendter CG
    Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotics in clinical practice: guidelines for safe and effective use.
    Curran S; Harris L; Macdonald A; Pollock C; Roney G; Silkstone D
    Hum Psychopharmacol; 2002 Mar; 17(2):75-82. PubMed ID: 12404695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
    Nasrallah HA
    Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.
    Høiberg MP; Nielsen B
    Nord J Psychiatry; 2006; 60(3):207-12. PubMed ID: 16720511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: Part 2. Metabolism and elimination.
    Preskorn SH
    J Psychiatr Pract; 2012 Sep; 18(5):361-8. PubMed ID: 22995963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: Part 3. Effects of renal and hepatic impairment.
    Preskorn SH
    J Psychiatr Pract; 2012 Nov; 18(6):430-7. PubMed ID: 23160248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotics.
    Johnson ST
    RN; 1997 Aug; 60(8):45-9; quiz 50. PubMed ID: 9287877
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of schizophrenia adverse drug interactions through a network approach and drug classification.
    Sun J; Zhao M; Fanous AH; Zhao Z
    Biomed Res Int; 2013; 2013():458989. PubMed ID: 24089679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical assessment of antipsychotic drug monitoring.
    Waraska J; Nagle JD
    Clin Lab Med; 1987 Jun; 7(2):435-52. PubMed ID: 2886247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Classification of neuroleptics].
    Simon P; Lecrubier Y; Puech AJ
    Rev Prat; 1984 Mar; 34(13):589-90, 593-4. PubMed ID: 6143385
    [No Abstract]   [Full Text] [Related]  

  • 38. Antipsychotic drugs in the general hospital: uses and cautions.
    Bernstein JG
    Psychosomatics; 1979 May; 20(5):335, 339, 342-3, passim. PubMed ID: 43555
    [No Abstract]   [Full Text] [Related]  

  • 39. [New classes of drugs in psychiatry].
    Chneiweiss L; Allilaire JF
    Rev Infirm; 1988 May; 38(9):37-41. PubMed ID: 2908679
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current data on antipsychotics].
    Thomas P
    Rev Prat; 2015 Feb; 65(2):248-50. PubMed ID: 25939235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.